Sectors > > Fate Therapeutics Inc

Fate Therapeutics Inc(NASDAQ:FATE)

Market Overview

3.28

0.17(4.93%)
Vol 314,857
10 Days Avg Vol 144000
3 Mo Avg Vol 14727700
52 Wk Lo/Hi $3.5 - $8.78
YTD Price Gain % 24.3%
10 Wks Moving Avg 5.76
200 Days Moving Avg 5.04
Liquidity Ratio 90.1
Market Cap 135,796,664

Related News View All

Summary

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of pharmacologic modulators of adult stem cells. It has built two platforms: HSC modulation platform and Satellite Cell modulation platform.

Contact Information


Fate Therapeutics Inc

Suite 200
3535 General Atomics Court

San Diego CA 92121

+1 858 875-180

None

info@fatetherapeutics.com

http://www.fatetherapeutics.com

Christian Weyer